


This is the story the prizewinning Wall Street Journal reporter John Carreyrou tells virtually to perfection. he company was the subject of adoring media profiles it attracted a who’s who of retired politicos to its board. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings-from journalists to their own employees.In Theranos’s brief, Icarus-like existence as a Silicon Valley darling. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. There was just one problem: The technology didn't work. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.5 billion. Carreyrou tells virtually to perfection." -The New York Times Book Review In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. her trial and sentencing, bringing the story to a close.

NATIONAL BESTSELLER * The gripping story of Elizabeth Holmes and Theranos-one of the biggest corporate frauds in history-a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist. Read more ISBNīad Blood: Secrets and Lies in a Silicon Valley Startup (Trade Paperback / Paperback) All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings-from journalists to their own employees.

NATIONAL BESTSELLER - The gripping story of Elizabeth Holmes and Theranos-one of the biggest corporate frauds in history-a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist.
